Evidence map›Paper›PMID 34576204›Full record

ReviewInternational journal of molecular sciences2021

Natural Products Counteracting Cardiotoxicity during Cancer Chemotherapy: The Special Case of Doxorubicin, a Comprehensive Review.

Izabela Koss-Mikołajczyk, Vanja Todorovic, Sladjana Sobajic, Jamal Mahajna, Marko Gerić, Josep A Tur, Agnieszka Bartoszek

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Drug Repositioning in Doxorubicin-Induced Cardiotoxicity Protection.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. International journal of molecular sciences · 2023
    Article
  19. Article
  20. In Vitro Evaluation of Ferutinin Rich-International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 5 countries.

Izabela Koss-MikołajczykDepartment of Food Chemistry, Technology and Biotechnology, Gdańsk University of Technology, 11/12 Narutowicza St., 80-233 Gdańsk, Poland.ORCID 0000-0002-1316-7673
Vanja TodorovicDepartment of Bromatology, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia.ORCID 0000-0002-6449-6450
Sladjana SobajicDepartment of Bromatology, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia.
Jamal MahajnaDepartment of Nutrition and Natural Products, Migal-Galilee Research Institute, Kiryat Shmona 11016, Israel.ORCID 0000-0003-2218-2039
Marko GerićMutagenesis Unit, Institute for Medical Research and Occupational Health, 10000 Zagreb, Croatia.
Josep A TurResearch Group on Community Nutrition & Oxidative Stress, University of Balearic Islands-IUNICS, IDISBA & CIBEROBN (Physiopathology of Obesity and Nutrition), 07122 Palma de Mallorca, Spain.ORCID 0000-0002-6940-0761
Agnieszka BartoszekDepartment of Food Chemistry, Technology and Biotechnology, Gdańsk University of Technology, 11/12 Narutowicza St., 80-233 Gdańsk, Poland.ORCID 0000-0002-6096-5838
Gdańsk University of Technology · PLUniversity of Belgrade · RSCentro de Investigación Biomédica en Red · ESInstitute for Medical Research and Occupational Health · HRMigal - Galilee Technology Center · IL

Funding

European Regional Development Fund 11/01791European Regional Development Fund 14/00636European Regional Development Fund 17/01827European Regional Development Fund CB12/03/30038European Regional Development Fund RD06/0045/1004Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja 451-03-9/2021-14/200161Narodowe Centrum Nauki 2014/14/A/ST4/00640
6 · The paper itself

Abstract

Cardiotoxicity is a frequent undesirable phenomenon observed during oncological treatment that limits the therapeutic dose of antitumor drugs and thus may decrease the effectiveness of cancer eradication. Almost all antitumor drugs exhibit toxic properties towards cardiac muscle. One of the underlying causes of cardiotoxicity is the stimulation of oxidative stress by chemotherapy. This suggests that an appropriately designed diet or dietary supplements based on edible plants rich in antioxidants could decrease the toxicity of antitumor drugs and diminish the risk of cardiac failure. This comprehensive review compares the cardioprotective efficacy of edible plant extracts and foodborne phytochemicals whose beneficial activity was demonstrated in various models in vivo and in vitro. The studies selected for this review concentrated on a therapy frequently applied in cancer, anthracycline antibiotic-doxorubicin-as the oxidative stress- and cardiotoxicity-inducing agent.

Indexed as

AnimalsAnthracyclinesAntioxidantsBiological ProductsDoxorubicinHumansPhytochemicalsAnthracyclinesAntioxidantsBiological ProductsDoxorubicinPhytochemicalsanthracyclinesantioxidantscardioprotectantscardiotoxicityphytochemicals

Identifiers

PMID34576204
PMCPMC8467966
OpenAlexW3200354186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.